Skip to content
Search AI Powered
Human content, AI powered search.

Latest Stories

Military Invests in MDMA for PTSD Treatment

In a historic shift, the Department of Defense is funding two major clinical trials—totaling $9.8 million—to study the use of MDMA-assisted therapy for treating PTSD in active-duty service members. The research marks the first sanctioned exploration of psychedelics within the military. While the move signals progress, broader access to alternative therapies like cannabis and psilocybin remains blocked—leaving many veterans still fighting for healing options the government won’t yet fund.

the pentagon, washington dc, aerial view

The Pentagon Is Betting Nearly $10 Million on MDMA to Treat PTSD in Active-Duty Soldiers

www.army.mil
Ezra Sterling
By Ezra SterlingMar 28, 2025
Ezra Sterling
Ezra Sterling is an emerging writer who specializes in crafting compelling and informative articles about the cannabis and psychedelics industries. With a background in botany and a passion for alternative medicine, Ezra has honed his skills as a digital wordsmith, focusing on educating the public about the potential benefits and risks of these substances.
See Full Bio
Follow:

The U.S. Department of Defense (DoD) has earmarked $9.8 million for pioneering research into the therapeutic potential of psychedelics, specifically MDMA, for active-duty service members grappling with post-traumatic stress disorder (PTSD). This initiative underscores a significant shift in military mental health strategies, acknowledging the pressing need for innovative treatments amid rising concerns over service members' well-being.Latest news & breaking headlines+1Military Times+1

Breaking Down the Investment

The funding is divided into two equal grants of $4.9 million:Military Times

  • Walter Reed National Military Medical Center: Set to conduct a double-blind, placebo-controlled trial, this study will administer MDMA to active-duty Army personnel diagnosed with mild to moderate PTSD. The primary objective is to assess how MDMA influences psychological flexibility, a key factor in effective PTSD treatment. Leading this research is Major Aaron Wolfgang, head of Inpatient Psychiatry at Walter Reed, who has previously contributed to comprehensive reviews on MDMA-assisted therapy. Military Times+1Latest news & breaking headlines+1
  • Emory University and STRONG STAR Consortium: Collaborating with the University of Texas Health Science Center at San Antonio, this partnership will explore MDMA-assisted therapy's efficacy in treating PTSD among active-duty troops. STRONG STAR is renowned for its focus on combat-related PTSD research, making it a pivotal player in this groundbreaking study.

A Historical Perspective

This endeavor marks the first sanctioned investigation into MDMA's therapeutic applications for PTSD within active-duty military personnel. Historically, the U.S. government's engagement with psychedelics in military contexts has been controversial, often associated with unauthorized experiments during the mid-20th century. This contemporary research signifies a departure from past practices, emphasizing scientific rigor and ethical standards.

The Broader Context: Veterans and Alternative Therapies

While the DoD's commitment to exploring psychedelics is a progressive step, it occurs against a backdrop of governmental resistance to alternative treatments for veterans. Efforts to expand access to cannabis and psychedelics for medical purposes have faced legislative hurdles. For instance, amendments proposing research into psilocybin and MDMA for PTSD and traumatic brain injury were recently rejected, leaving many veterans without access to potentially life-changing therapies.

FDA Approves Landmark Cannabis for PTSD in Veterans - The BluntnessFDA Approves Landmark Cannabis for PTSD in Veterans - The Bluntness Photo by Wesley Tingey on Unsplash

The Imperative for Innovative Solutions

The urgency for effective mental health interventions in the military community cannot be overstated. Studies have shown that women veterans are 1.8 times more likely than their civilian counterparts to commit suicide, highlighting the critical need for comprehensive and effective treatment options.

The DoD's $9.8 million investment in psychedelic research represents a hopeful development in addressing the complex mental health challenges faced by service members. As these studies progress, they hold the potential to reshape treatment paradigms and offer new avenues for healing to those who have served.

The Latest

Giphy of Rodney Dangerfield stretching and experiencing back-pain, in an exaggerated/funny manner
Wellness

CBD & THC for Athletes

Jack Herer: The Legendary Daytime Strain
Wellness

Jack Herer: Cannabis Royalty

OCM Alleges 'Rent-a-License' Scheme, Seeks License Revocation
News

NY Revokes License in Rent-a-License Scam

OG Kush: The West Coast Legend
Wellness

OG Kush: West Coast Classic

More For You

Comprehensive Glossary of Cannabis Terminology - The Bluntness
Cannabis Terminology - The Bluntness
Photo by Margo Amala on Unsplash

Are You Ready to Master Cannabis Lingo? Explore Essential Terms Now

This glossary covers key cannabis-related terms that can help consumers better understand the cannabis industry, products, and their effects. Whether you're new to cannabis or looking to deepen your knowledge, these definitions offer clarity on common terms you might encounter.

Cannabis Basics: What is Cannabis?

Cannabis is a fascinating plant species that includes three main types: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Each of these species has unique characteristics and effects. The cannabis plant is a complex organism, rich in various compounds such as cannabinoids, terpenes, and flavonoids. These compounds contribute to the plant’s diverse range of effects and therapeutic benefits. Cannabis plants are cultivated for both medicinal and recreational purposes, and they can be consumed in multiple forms, including dried flower, extracts, and edibles. Whether you’re interested in the energizing effects of Cannabis sativa, the relaxing properties of Cannabis indica, or the unique traits of Cannabis ruderalis, there’s a cannabis plant to suit every need.

Cannabis Products: Cannabis Extracts

Cannabis extracts are highly potent products derived from the cannabis plant using various extraction methods, such as solvents or CO2. These extracts are concentrated forms of cannabis that can be used in several ways, including dabbing, vaporizing, or as ingredients in edibles and topicals. There are several types of cannabis extracts, each with its own texture and potency, including wax, shatter, oil, and crumble. These products are often favored for their high cannabinoid content and are commonly used for medicinal purposes, such as pain relief and anxiety management. Whether you’re looking for a powerful dabbing experience or a potent ingredient for your homemade edibles, cannabis extracts offer a versatile and effective option.

Keep ReadingShow less
a crudely rolled lit joint being passed to camera
Photo by Chase Fade on Unsplash

Alcohol vs Marijuana: Alcohol Worse?

Turns out, your friend who swapped tequila shots for THC gummies might be on to something. A new poll has found that a majority of Americans now believe alcohol is more harmful to a person’s health than marijuana—and frankly, it’s about time. The severe health risks associated with alcohol use, including addiction, various diseases, and a high incidence of mortality, are becoming more widely recognized.

The survey, conducted by YouGov, asked over 1,000 U.S. adults to weigh in on which substance does more damage: good ol’ booze or that plant that’s still somehow federally illegal. The verdict? 64% of respondents said alcohol is more dangerous, compared to just 27% who pointed the finger at weed. The rest? They couldn’t decide or didn’t care enough to pick.

Keep ReadingShow less
Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Giphy

Aging & Cannabis: New Findings

For decades, cannabis has been widely regarded as a substance with potential cognitive risks, particularly when used over long periods. Governments across the globe have classified it as a controlled substance, citing concerns about the effects of marijuana use, including memory loss, diminished executive function, and long-term neurological impact. But new research is challenging this long-standing assumption, suggesting that cannabis use may not be linked to age-related cognitive decline—and might even be associated with better cognitive preservation over time.

A recent study published in PubMed (NIH, 2024) followed over 5,000 men for more than four decades to analyze the long-term cognitive effects of cannabis use. The results? Men with a history of cannabis use experienced less cognitive decline from early adulthood to late midlife compared to those who never used cannabis.

Keep ReadingShow less
Hall of Flowers NYC 2025: Cali Vibes Minus the Pulse of NY Cannabis

Hall of Flowers NYC Debut: Cali Vibes Minus the Pulse of NY Cannabis

Photo courtesy of Hall of Flowers

Hall of Flowers NYC 2025: Cali Vibes Minus the Pulse of NY Cannabis

Upon entering through the doors at Pier 36 it was refreshing to see row after row of identical booths, neat as a spreadsheet, designed to let the product speak for itself. Buyers drifted through the aisles with line sheets instead of selfie sticks, the volume dialed way down compared to last month's Revelry event at the same location. And, maybe that was the point. Hall of Flowers’ first New York edition was designed for commerce, not commotion: a buyers-only opening day, tight credentialing, a controlled environment and pace that favored real conversations over spectacle.

The uniformity of Hall of Flowers' format erased the booth-flex arms race; most of the brands stood shoulder-to-shoulder on product, pricing, and execution. “Much easier to have conversations here than at Revelry,” several attendees told us. Others called it “weak” or “quiet” by comparison. One marketing exec involved in the event went all in saying, “Revelry is a flea market compared to Hall of Flowers.” What he meant by that is: Hall of Flowers is a curated, high-end trade event, whereas Revelry functions more as a community marketplace. I could see his point.

Keep ReadingShow less
Diverse mix of people sitting outdoors, around a table smiling at camera
Hall of Flowers 2025: Why This Santa Rosa Showcase Remains a Standard Bearer for Cannabis Trade Shows
Press photo provided by Hall of Flowers

Hall of Flowers 2025: Cannabis Trade Show Leader

The cannabis industry has no shortage of events, but very few manage to balance business, culture, and community the way Hall of Flowers does. Since its launch in 2018, the Santa Rosa-based show has become a must-attend gathering for licensed brands, retailers, investors, and innovators.

This year’s edition takes place September 10–11, 2025, at the Sonoma County Fairgrounds, continuing a legacy that goes far beyond trade show floor traffic. Hall of Flowers has become a barometer for where cannabis is now and where it's heading—and how brands and buyers can stay ahead of the curve.

Keep ReadingShow less